Thursday, July 16, 2026

11:15 AM - 1:15 PM

---

Details

Most studies of drug interaction are done of pairs in healthy volunteers. In the real world, use of multiple medicines is the norm, allowing great scope to look for harmful or beneficial interactions across all populations. This symposium will showcase research using real world data that explores risks for adverse effects, death, overdose, adherence, and persistence. It will also explore barriers to translation of this research into product information and guidelines. Talks: 1) Real world evidence on novel lethal drug interactions – and the barriers to translation into guidelines and practice. 2) Combinations of drugs linked to poisoning and suicide, making better use of post-mortem toxicology data. 3) Psychotropic drug polypharmacy – an evolving problem from childhood to old age. 4) Using Systems Pharmacology to generate hypotheses for pharmaco-epidemiological investigation 5) Polypharmacy and adherence trajectories – the complex connection between what you take and how well you stick to it.

---

Session chair